Stay updated on Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Sign up to get notified when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.

Latest updates to the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page
- CheckyesterdayChange DetectedThe web page has updated its clinical references regarding COVID-19, adding new studies while removing previous ones, indicating a shift in the focus of the content towards more recent research.SummaryDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes in the description of a clinical trial for COVID-19 treatments, including updates to the trial design and the removal of detailed background information on COVID-19 and its impact on high-risk individuals.SummaryDifference31%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.